𝔖 Bobbio Scriptorium

✦ LIBER ✦

Association between ERCC1 and TS mRNA levels and disease free survival in colorectal cancer patients receiving oxaliplatin and fluorouracil (5-FU) adjuvant chemotherapy

✍ Scribed by Sheng Li,Liangjun Zhu,Li Yao,Lei Xia,Liangxi Pan

Book ID: 126370364
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 365 KB
Volume: 14
Category: Article
ISSN: 1471-230X
DOI: 10.1186/1471-230X-14-154

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

283 Evaluation of thymidine phosphorylas

283 Evaluation of thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA levels in colorectal cancer reveals significant correlations to tumor histopathology and disease-free survival in 5-FU treated patients

✍ S. Lassmann; M. Hennig; R. Rosenberg; J. Nährig; J. Schreglmann; F. Krause; M. P 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Adjuvant chemotherapy with oxaliplatin,

Adjuvant chemotherapy with oxaliplatin, in combination with fluorouracil plus leucovorin prolongs disease-free survival, but causes more adverse events in people with stage II or III colon cancer: Abstracted from: André T, Boni C, Mounedji-Boudiaf L, et al. Multicenter international study of oxaliplatin/5-fluorouracil/leucovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343–51

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 213 KB